Ilaria Sciomenta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ilaria Sciomenta has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adam Lukacs
EIT Health, 80807 Munich, Germany
1 shared publication - Americo Cicchetti
Graduate School of Health Economics and Management (ALTEMS), Università Cattolica del Sacro Cuore, 00168 Rome, Italy
1 shared publication - Dario Sacchini
Department of Healthcare Surveillance and Bioethics, Section of Bioethics and Medical Humanities, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
1 shared publication - Debora Antonini
Altems Advisory, spin-off dell’Università Cattolica del Sacro Cuore, Roma - Italy
1 shared publication - Elena Maria Calosci
ALTEMS ADVISORY, Università Cattolica del Sacro Cuore
1 shared publication - Emmanouil Tsiasiotis
Università Cattolica del Sacro Cuore, Graduate School of Health Economics and management
1 shared publication
Latest Publications
- Open Access
- 4 September 2025
- Published by MDPI AG in Journal of Market Access & Health Policy
- Vol. 13 (3) , 46
Shaping the Future of DHT Assessment: Insights on Industry Challenges, Developer Needs, and a Harmonized, European HTA Framework
Introduction: Market access, pricing, and reimbursement of digital health technologies (DHTs) in Europe are significantly challenged by regulatory fragmentation and various assessment methodologies. Understanding the challenges and priorities of technology developers is essential for developing effective and relevant policy responses. This study explores perceived barriers and developer-driven priorities to inform the development of a harmonized health technology assessment (HTA) framework under the EDiHTA project. Methods: A mixed-methods approach was adopted, including a scoping review to identify key challenges, a survey of 20 DHT developers, and interviews and focus groups with 29 industry representatives from startups to multinational companies across 10 European countries during 2024. Results: Key challenges included a lack of transparency in reimbursement processes, fragmented HTA requirements, and misalignment between traditional evidence models and the agile development of DHTs. Developers highlighted the need to integrate real-world evidence, consider usability and implementation factors, and provide structured, lifecycle-based guidance. Financial barriers and procedural burdens were particularly significant for small and medium-sized enterprises. Conclusions: These findings highlight the need for an HTA framework that reflects the iterative nature of digital development, integrates real-world evidence, and reduces uncertainty for developers. The EDiHTA project aims to respond to these challenges by building a harmonized and flexible approach that aligns with the goals of the European HTA Regulation.
- 4 September 2025
- Published by MDPI AG in Journal of Market Access & Health Policy
- Vol. 13 (3) , 46
Open AccessShaping the Future of DHT Assessment: Insights on Industry Challenges, Developer Needs, and a Harmonized, European HTA Framework
Introduction: Market access, pricing, and reimbursement of digital health technologies (DHTs) in Europe are significantly challenged by regulatory fragmentation and various assessment methodologies. Understanding the challenges and priorities of technology developers is essential for developing effective and relevant policy responses. This study explores perceived barriers and developer-driven priorities to inform the development of a harmonized health technology assessment (HTA) framework under the EDiHTA project. Methods: A mixed-methods approach was adopted, including a scoping review to identify key challenges, a survey of 20 DHT developers, and interviews and focus groups with 29 industry representatives from startups to multinational companies across 10 European countries during 2024. Results: Key challenges included a lack of transparency in reimbursement processes, fragmented HTA requirements, and misalignment between traditional evidence models and the agile development of DHTs. Developers highlighted the need to integrate real-world evidence, consider usability and implementation factors, and provide structured, lifecycle-based guidance. Financial barriers and procedural burdens were particularly significant for small and medium-sized enterprises. Conclusions: These findings highlight the need for an HTA framework that reflects the iterative nature of digital development, integrates real-world evidence, and reduces uncertainty for developers. The EDiHTA project aims to respond to these challenges by building a harmonized and flexible approach that aligns with the goals of the European HTA Regulation.